
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
T1R2 CRISPR/Cas9 KO Plasmid (h) | sc-402555 | 20 µg | $397.00 |
TAS1R2 encodes the sweet taste receptor subunit T1R2, a class C GPCR that heterodimerizes with T1R3 to detect sugars and sweeteners and couple ligand binding to intracellular second-messenger signaling. Beyond gustatory cells, T1R2/T1R3 signaling has been reported in enteroendocrine and other chemosensory contexts where it can influence nutrient sensing and downstream hormone or metabolic responses. Receptor activation is commonly linked to GPCR-mediated pathways involving G proteins, PLCβ2, intracellular Ca²⁺ mobilization, and downstream MAPK or transcriptional programs depending on cell type. Altered TAS1R2 expression or variants have been investigated in relation to metabolic phenotypes, dietary behavior, and glucose homeostasis, supporting its relevance for studies of nutrient-responsive signaling networks.
T1R2 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the TAS1R2 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the TAS1R2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the TAS1R2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish T1R2 protein expression.
This CRISPR knockout system enables efficient generation of TAS1R2-deficient cell models for investigation of T1R2 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.